Brian M. Cohen

A New Look at Myelomeningoceles: Functional Level, Vertebral Level, Shunting, and the Implications for Fetal Intervention

Natalie E. Rintoul, Leslie N. Sutton, Anne M. Hubbard et al. · PEDIATRICS · 2002 · 292 citations

Medicine, Neurological Surgery, Pediatrics +13

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor

Russell L. Basser, Elizabeth O’Flaherty, Michael Green et al. · Blood · 2002 · 246 citations

Medicine, Hematology, Oncology +10

Late cognitive and radiographic changes related to radiotherapy

Carol L. Armstrong, Jill V. Hunter, George E. Ledakis et al. · Neurology · 2002 · 214 citations

Medicine, Oncology, Radiation Oncology +17

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Russell L. Basser, John E.J. Rasko, Kerrie Clarke et al. · PubMed · 1997 · 201 citations

Medicine, Oncology, Chemotherapy +8

The Effect of Intrauterine Myelomeningocele Repair on the Incidence of Shunt-Dependent Hydrocephalus

Noel Tulipan, Leslie N. Sutton, Joseph P. Bruner et al. · Pediatric Neurosurgery · 2002 · 186 citations

Medicine, Pediatrics, Surgery +9